Vasil Vasilev

ORCID: 0000-0001-7588-2165
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Lupus Erythematosus Research
  • Complement system in diseases
  • Renal Diseases and Glomerulopathies
  • Iron Metabolism and Disorders
  • Hemoglobinopathies and Related Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • Adrenal and Paraganglionic Tumors
  • Trace Elements in Health
  • Bladder and Urothelial Cancer Treatments
  • Blood groups and transfusion
  • Immune Cell Function and Interaction
  • Pituitary Gland Disorders and Treatments
  • Mitochondrial Function and Pathology
  • T-cell and B-cell Immunology
  • Hormonal Regulation and Hypertension
  • Tuberculosis Research and Epidemiology
  • Angiogenesis and VEGF in Cancer
  • Erythropoietin and Anemia Treatment
  • Platelet Disorders and Treatments
  • Reproductive System and Pregnancy
  • Atherosclerosis and Cardiovascular Diseases
  • Gut microbiota and health
  • Hemoglobin structure and function
  • Epigenetics and DNA Methylation
  • Diet and metabolism studies

Medical University of Sofia
2013-2024

Queen Giovanna Hospital
2010-2024

Alexandrovska Hospital
2015-2022

University of South Australia
2020

Medical University of Varna
2020

Bulgarian Academy of Sciences
2018

Institute of Biodiversity and Ecosystem Research
2018

Centar za Promociju Nauke
2018

Introduction Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that can affect substantially any organ in the body. One of its most severe manifestations nephritis. Hereditary C1q deficiency strongly related to SLE but there are very few and inconsistent studies exploring single nucleotide polymorphisms (SNPs) gene cluster relation pathogenesis SLE. In present study we evaluated possible association variants complement with susceptibility nephritis Bulgarian population,...

10.1177/0961203314555173 article EN Lupus 2014-10-17

A microfluidic sensor was studied for the photometric detection of active chlorine, total and pH in swimming pool samples. The consisted a four-layer borosilicate glass chip, containing microchannel network 2.2 mm path length, 1.7 mL optical cell. chip optimised to measure bleaching methyl orange spectral changes phenol red quantitative chlorine (active total) measurements that were suited monitoring. Reagent consumption (60 per measurement) minimised allow maintenance-free operation over...

10.3390/s20113099 article EN cc-by Sensors 2020-05-30

IntroductionComplement system overactivation is pivotal in LN pathophysiology. As anti-C3 autoantibodies play a significant role pathophysiology, we explored them as disease activity biomarkers and compared to the ones against homologous protein C4.MethodsWe investigated presence of anti-C4 IgG cohort (n=85 patients) monitored their changes over time. We correlated autoantibody with clinical parameters. conducted cross-sectional longitudinal analyses (n=295 samples, 8 years follow-up)...

10.1016/j.ekir.2024.01.052 article EN cc-by Kidney International Reports 2024-02-02

Data on the prevalence of macroprolactinemia in patients with prolactinomas is quite limited as presence high-molecular prolactin forms suspected mainly subjects mild hyperprolactinemia and negative pituitary imaging. The main objective this observational case-control study was to assess clinical significance among prolactinomas. population consisted 239 subjects: 131 prolactinoma 108 sex-, age- ethnicity– matched healthy controls. Macroprolactinemia defined by a PRL recovery after PEG...

10.1055/s-0032-1333232 article EN Experimental and Clinical Endocrinology & Diabetes 2013-04-17

Autoantibodies against the complement component C1q (anti-C1q) are among main biomarkers in lupus nephritis (LN) known to contribute renal injury. C1q, recognition subcomponent of classical pathway, forms a heterotetrameric complex with C1r and C1s, can also associate central regulator C1 Inhibitor (C1-Inh). However, frequency pathogenic relevance anti-C1r, anti-C1s anti-C1-Inh autoantibodies remain poorly studied LN. In this paper, we screened for anti-C1q, evaluated their association...

10.3390/ijms23169281 article EN International Journal of Molecular Sciences 2022-08-17

Lupus nephritis (LN) is a disease marked by autoantibodies against complement components. Autoantibodies negative regulator factor H (anti-FH) are prevalent in aHUS, associated with deletion of H-related protein 1 (FHR1) gene, and have overt functional consequences. They also observed C3 glomerulopathies. The frequency relevance anti-FH LN poorly studied. aim our investigation was to screen for the presence FHR1 gene cohort patients evaluate their association activity. ELISA test Western...

10.1016/j.medcli.2024.05.019 article ES cc-by-nc Medicina Clínica 2024-07-14

Vascular endothelial growth factor (VEGF) is secreted from cells and pericytes in response to hypoxia. It induces angiogenesis microvascular hyperpermeability. We observe serum VEGF concentrations some patients with vasculitic neuropathy.Plasma was measured using GenWay's human ELISA Kit, which based on standard sandwich enzyme-linked immune-sorbent assay technology. Human specific-specific monoclonal antibodies are precoated onto 96-well plates. The specific detection polyclonal...

10.7754/clin.lab.2013.130622 article EN Clinical Laboratory 2014-01-01

IntroductionThe aim of the present study was to evaluate influence clinicopathological factors including age, gender, tumor grade, stage, lymphovascular invasion (LVI), necrosis and previous history non-muscle invasive bladder cancer on outcomes patients with upper tract urothelial carcinoma (UTUC) treated radical nephroureterectomy (RNU).Material methods A total 60 who underwent for at our institute between 2005 2012 were included in study.Univariate multivariate analysis performed using...

10.5173/ceju.2016.713 article EN Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication 2016-01-01

Summary Properdin is the only positive regulator of complement system. In this study, we characterize prevalence, functional consequences and disease associations autoantibodies against properdin in a cohort patients with autoimmune systemic lupus erythematosus (SLE) suffering from nephritis (LN). We detected plasma 22·5% LN (16 71) by enzyme-linked immunosorbent assay (ELISA). The binding these to was dose-dependent validated surface plasmon resonance. Higher levels anti-properdin were...

10.1111/cei.13443 article EN Clinical & Experimental Immunology 2020-04-19

Summary Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. quantification in human blood may provide further insights for the pathogenesis of disorders homeostasis and might prove valuable tool clinicians differential diagnosis anaemia. This study describes ELISA immunoassay hepcidin serum. We used sandwich method from USCN Life Science inc., that consists ready to use, pre-coated 96-well strip plate with 2 antihepcidin-25 monoclonal antibodies. A recombinant 16 μg/l...

10.2478/amb-2014-0003 article EN cc-by-nc-nd Acta Medica Bulgarica 2014-06-01

Epigenetic modifications of genomes are particular interest as numerous studies indicate the correlation between DNA methylation and development systemic lupus. As a major methyl group donor, folic acid is an important participant in this process. The aim study to determine effect low or high dose folate co-culturing with peripheral blood mononuclear cells (PBMCs) on secretion interleukin (IL)10 from regulatory lupus patients healthy volunteers.PBMCs volunteers were isolated separated CD19+...

10.1111/1756-185x.14496 article EN International Journal of Rheumatic Diseases 2022-11-17

Introduction. The syndrome of mobile claw toes or, as it is commonly called in the English-language scientific literature, checkrein deformity a rare dynamic that develops secondary to any traumatic factor at level ankle joint and foot. A special aspect clinical example presented pathology developed without direct impact on above-mentioned anatomical areas. We have not found references or descriptions such observation literature available. aim publication was demonstrate patient with...

10.20969/vskm.2024.17(6).120-127 article EN The Bulletin of Contemporary Clinical Medicine 2024-11-01

Diabetes mellitus (DM) is a metabolic disease of chronic insulin deficiency or resistance. The progression DM associated with long-term damage to macro- and micro-vascular body systems causes serious health complications. Up 40% patients develop kidney (CKD), mainly as consequence diabetic nephropathy (DN). Hence, strict glycemic control recommended slow down CKD progression. Hyperglycemia complications in through the glycation various proteins. interaction glucose free NH2 groups proteins...

10.7546/crabs.2024.03.15 article EN Proceedings of the Bulgarian Academy of Sciences 2024-03-31
Coming Soon ...